The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease

Kidney International

Volumn 74, Issue 4, 2008, Pages 495-504

  Eardley, Kevin S ^a,b   Kubal, Chandrashekhar ^b,c   Zehnder, Daniel ^d   Quinkler, Marcus ^e   Lepenies, Julia ^c   Savage, Caroline O ^b,c   Howie, Alec J ^f   Kaur, Kirrenjit ^b   Cooper, Mark S ^b   Adu, Dwomoa ^b,c   Cockwell, Paul ^b,c  

^a ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e Centre for Internal Medicine Gastroenterology Hepatology and Endocrinology   (Germany)

^f ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Capillaries; Chronic kidney disease; Hypoxia; Macrophages; MCP 1 CCL2; VEGF

Indexed keywords

ALBUMIN; CARBONATE DEHYDRATASE IX; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; HUMAN; HYPERTENSION; HYPOXEMIA; ISCHEMIA; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY SCAR; LEYDIG CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MEASUREMENT; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEINURIA; UPREGULATION; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CAPILLARIES; CELL COUNT; CHEMOKINE CCL2; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; MACROPHAGES; MIDDLE AGED; MONOCYTES; PROTEINURIA; RNA, MESSENGER;

EID: 48649099815     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.183     Document Type: Article

References (36)

1. Sean Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005; 68: 437-455.
2. Eardley KS, Zehnder D, Quinkler M et al. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 2006; 69: 1189-1197.
3. Grandaliano G, Gesualdo L, Ranieri E et al. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 1996; 7: 906-913.
4. Kitagawa K, Wada T, Furuichi K et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004; 165: 237-246.
5. Prodjosudjadi W, Gerritsma JS, van Es LA et al. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 1995; 44: 148-155.
6. Segerer S, Cui Y, Hudkins KL et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 2231-2242.
7. Shimizu H, Maruyama S, Yuzawa Y et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol 2003; 14: 1496-1505.
8. Tang WW, Qi M, Warren JS et al. Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 1997; 159: 870-876.
9. Wada T, Furuichi K, Sakai N et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004; 15: 940-948.
10. Yoshimoto K, Wada T, Furuichi K et al. CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy. Nephron Clin Pract 2004; 98: c25-c34.
11. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996; 19: 191-195.
12. Choi YJ, Chakraborty S, Nguyen V et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 2000; 31: 1491-1497.
13. Futrakul P, Yenrudi S, Sensirivatana R et al. Renal perfusion and nephronal structure. Nephron 1999; 82: 79-80.
14. Seron D, Alexopoulos E, Raftery MJ et al. Number of interstitial capillary cross-sections assessed by monoclonal antibodies: relation to interstitial damage. Nephrol Dial Transplant 1990; 5: 889-893.
15. Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 2000; 75: S22-S26.
16. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
17. Shweiki D, Itin A, Soffer D et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
18. Namikoshi T, Satoh M, Horike H et al. Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol 2006; 102: 9-16.
19. Combe C, Burton CJ, Dufourco P et al. Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells. Kidney Int 1997; 51: 1703-1709.
20. Lewis JS, Lee JA, Underwood JC et al. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 1999; 66: 889-900.
21. Manotham K, Tanaka T, Matsumoto M et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004; 15: 1277-1288.
22. Matsumoto M, Tanaka T, Yamamoto T et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 2004; 15: 1574-1581.
23. Futrakul N, Yenrudi S, Sensirivatana R et al. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren Fail 2000; 22: 329-335.
24. Manotham K, Tanaka T, Matsumoto M et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 2004; 65: 871-880.
25. Norman JT, Orphanides C, Garcia P et al. Hypoxia-induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol 1999; 7: 463-469.
26. Jubb AM, Pham TQ, Hanby AM et al. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours. J Clin Pathol 2004; 57: 504-512.
27. Wykoff CC, Beasley NJ, Watson PH et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000; 60: 7075-7083.
28. Loncaster JA, Harris AL, Davidson SE et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 2001; 61: 6394-6399.
29. Hui EP, Chan AT, Pezzella F et al. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 2002; 8: 2595-2604.
30. Li X, Kimura H, Hirota K et al. Hypoxia reduces constitutive and TNF-alpha-induced expression of monocyte chemoattractant protein-1 in human proximal renal tubular cells. Biochem Biophys Res Commun 2005; 335: 1026-1034.
31. Segerer S, Alpers CE. Chemokines and chemokine receptors in renal pathology. Curr Opin Nephrol Hypertens 2003; 12: 243-249.
32. Segerer S, Hughes E, Hudkins KL et al. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 2002; 62: 488-495.
33. Green SR, Han KH, Chen Y et al. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J Immunol 2006; 176: 7412-7420.
34. Barlic J, Zhang Y, Foley JF et al. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway. Circulation 2006; 114: 807-819.
35. Howie AJ, Ferreira MA, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 2001; 16: 1163-1169.
36. Quinkler M, Zehnder D, Eardley KS et al. Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation 2005; 112: 1435-1443.